Stefania Melini

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

PERSISTENT MOLECULAR SCARS AND GUT-BRAIN AXIS REMODELING AFTER ACUTE DSS COLITIS.

PERSISTENT MOLECULAR SCARS AND GUT-BRAIN AXIS REMODELING AFTER ACUTE DSS COLITIS.

Journal: Pharmacological research
Published: June 19, 2026

2-Pentadecyl-2-oxazoline alleviates anxiety-like behaviour and modulates the microbiota-gut-brain axis in obese mice.

2-Pentadecyl-2-oxazoline alleviates anxiety-like behaviour and modulates the microbiota-gut-brain axis in obese mice.

Journal: Frontiers in pharmacology
Published: May 11, 2026

A portable and versatile rGO-Co3O4-Pt nanocomposite-based electrochemical sensor for ex vivo and in vivo cardiac oxidative stress monitoring.

A portable and versatile rGO-Co3O4-Pt nanocomposite-based electrochemical sensor for ex vivo and in vivo cardiac oxidative stress monitoring.

Journal: Nanoscale
Published: November 07, 2025

Uncovering the pleiotropic effects of oleoylethanolamide on obesity-driven chronic kidney disease in mice.

Uncovering the pleiotropic effects of oleoylethanolamide on obesity-driven chronic kidney disease in mice.

Journal: European journal of pharmacology
Published: June 20, 2025

Novel insights into the hepatoprotective mechanisms of SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.

Novel insights into the hepatoprotective mechanisms of SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.

Journal: Frontiers in pharmacology
Published: June 18, 2025

Non-dioxin-like polychlorinated biphenyls (PCB 101, 153, and 180) and adipocyte lipid dysfunctions: Involvement of glycerol and role of aquaglyceroporins in mature 3T3-L1 cells.

Non-dioxin-like polychlorinated biphenyls (PCB 101, 153, and 180) and adipocyte lipid dysfunctions: Involvement of glycerol and role of aquaglyceroporins in mature 3T3-L1 cells.

Journal: Toxicology
Published: November 14, 2024

Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders.

Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders.

Journal: Frontiers in psychiatry
Published: November 07, 2024

Oleoylethanolamide mitigates cardiometabolic disruption secondary to obesity induced by high-fat diet in mice.

Oleoylethanolamide mitigates cardiometabolic disruption secondary to obesity induced by high-fat diet in mice.

Journal: Life sciences
Published: September 12, 2024

Sex Differences in Hepatic Inflammation, Lipid Metabolism, and Mitochondrial Function Following Early Lipopolysaccharide Exposure in Epileptic WAG/Rij Rats.

Sex Differences in Hepatic Inflammation, Lipid Metabolism, and Mitochondrial Function Following Early Lipopolysaccharide Exposure in Epileptic WAG/Rij Rats.

Journal: Antioxidants (Basel, Switzerland)
Published: July 03, 2024

Co-Micronized Palmitoylethanolamide and Rutin Associated With Hydroxytyrosol Recover Diabesity-Induced Hepatic Dysfunction in Mice: In Vitro Insights Into the Synergistic Effect.

Co-Micronized Palmitoylethanolamide and Rutin Associated With Hydroxytyrosol Recover Diabesity-Induced Hepatic Dysfunction in Mice: In Vitro Insights Into the Synergistic Effect.

Journal: Phytotherapy research : PTR
Published: May 10, 2024

Targeting liver and adipose tissue in obese mice: Effects of a N-acylethanolamine mixture on insulin resistance and adipocyte reprogramming.

Targeting liver and adipose tissue in obese mice: Effects of a N-acylethanolamine mixture on insulin resistance and adipocyte reprogramming.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 04, 2024

Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement.

Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 16, 2023
Showing 1-12 of 15

Last Updated: 09/26/2026